Shanghai Synergy Pharmaceutical Sciences, Zhejiang Huahai Pharmaceutical present BRD4 inhibitors Oct. 27, 2020
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent anti-claudin 18.2 antibodies Oct. 27, 2020